DeepMed Research

DD-S052P

Generic Name: DD-S052P

Clinical Trials

NextGen - Clinical Implication of Next Generation Sequencing

Phase 4

Recruiting

Conditions: Urinary Tract Infections

Interventions: Drug: Antibiotic
Device: Next Gen

First Posted Date: 2022-01-25

Last Posted Date: 2024-12-27

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 100

Registration Number: NCT05206500

Locations: 🇺🇸
Wake Forest Health Sciences, Winston-Salem, North Carolina, United States

Effect of Probiotic on Gut Microbiome and Bacterial Translocation in Healthy Asian Volunteers

Phase 4

Conditions: Dysbiosis

Interventions: Drug: Colonic lavage with polyethylene glycol
Dietary Supplement: Probiotic
Drug: Antibiotic

First Posted Date: 2021-10-19

Last Posted Date: 2022-03-22

Lead Sponsor: Changi General Hospital

Target Recruit Count: 32

Registration Number: NCT05083572

Locations: 🇸🇬
Changi General Hospital, Singapore, Singapore

Comparison The Postoperative Effects of Local and Systemic Antibiotics Applied With Platelets Rich Fibrin

Completed

Conditions: Impacted Wisdom Tooth

Interventions: Diagnostic Test: Diagnosis
Procedure: traditional osteotomies
Biological: Platelet Rich Fibrin
Drug: Antibiotics, Penicillin
Drug: Analgesic
Drug: Antibiotic

First Posted Date: 2021-08-04

Last Posted Date: 2024-03-22

Lead Sponsor: Ceren Melahat Donmezer

Target Recruit Count: 75

Registration Number: NCT04989127

Locations: 🇨🇾
Near east University, Nicosia, Lefkosa, Cyprus

Efficacy of Antibiotic Short Course for Bloodstream Infections in Acute Myeloid Leukemia Patients With Febrile Neutropenia

Completed

Conditions: Bloodstream Infection
Acute Myeloid Leukemia
Febrile Neutropenia

Interventions: Drug: Antibiotic

First Posted Date: 2021-06-02

Last Posted Date: 2021-06-02

Lead Sponsor: Poitiers University Hospital

Target Recruit Count: 104

Registration Number: NCT04910698

Locations: 🇫🇷
University Hospital, Poitiers, France

Per Oral Versus Intravenous Postoperative Antibiotics After Surgery for Complicated Appendicitis.

Not Applicable

Completed

Conditions: Complicated Appendicitis

Interventions: Drug: Antibiotic

First Posted Date: 2021-03-17

Last Posted Date: 2024-10-01

Lead Sponsor: Zealand University Hospital

Target Recruit Count: 3193

Registration Number: NCT04803422

Locations: 🇩🇰
Department of Surgery, Slagelse Hospital, Slagelse, Denmark
🇩🇰
Slagelse Hospital, Department of Surgery, Slagelse, Denmark

No Monitoring of Post-filter Ionized Calcium in Regional Citrate Anticoagulation

Not Applicable

Completed

Conditions: Regional Citrate Anticoagulation
Ionized Calcium
Continuous Renal Replacement Therapy

Interventions: Other: Regional citrate anticoagulation
Drug: Vasopressor
Drug: Antibiotic
Device: Dialysis with continuous renal replacement therapy

First Posted Date: 2021-03-11

Last Posted Date: 2022-11-14

Lead Sponsor: Chulalongkorn University

Target Recruit Count: 50

Registration Number: NCT04792424

Locations: 🇹🇭
Chulalongkorn university, Bangkok, Thailand

The HYsteroscopic Miscarriage MaNagement Trial: A Pilot RCT Investigating a Novel Management Pathway for RPOC

Not Applicable

Completed

Conditions: Retained Products After Miscarriage

Interventions: Procedure: Outpatient hysteroscopy
Behavioral: Expectant management
Drug: Medical management
Drug: Antibiotic
Procedure: Surgical management

First Posted Date: 2021-02-12

Last Posted Date: 2023-08-14

Lead Sponsor: Birmingham Women's and Children's NHS Foundation Trust

Target Recruit Count: 149

Registration Number: NCT04751500

Locations: 🇬🇧
Birmingham Women's Hospital, Birmingham, United Kingdom

Use of Preoperative and Postoperative Antimicrobial Treatment

Phase 4

Conditions: Surgical Site Infection
Antibiotic Side Effect
Ear Infection Bacterial

Interventions: Drug: Antibiotic

First Posted Date: 2021-01-13

Last Posted Date: 2021-10-04

Lead Sponsor: Sunnybrook Health Sciences Centre

Target Recruit Count: 304

Registration Number: NCT04707092

Locations: 🇨🇦
Sunnybrook Health Sciences Center, Toronto, Canada

CiproPAL (Ciprofloxacin Prophylaxis in Acute Leukaemia)

Not Applicable

Recruiting

Conditions: Acute Lymphoblastic Leukaemia - Category

Interventions: Drug: Ciprofloxacin
Drug: Antibiotic

First Posted Date: 2020-12-22

Last Posted Date: 2024-03-08

Lead Sponsor: University College, London

Target Recruit Count: 1052

Registration Number: NCT04678869

Locations: 🇬🇧
Addenbrookes Hospital, Cambridge, United Kingdom
🇬🇧
Nottingham Children's Hospital, Nottingham, United Kingdom
🇬🇧
Bristol Royal Hospital for Children, Bristol, United Kingdom

and more 11 locations

Utility of Empiric Antibiotics for Non-intubated Novel Coronavirus Diseases 2019 Patients

Withdrawn

Conditions: Covid19
Coronavirus Infection
Pneumonia

Interventions: Drug: Antibiotic

First Posted Date: 2020-12-19

Last Posted Date: 2024-03-22

Lead Sponsor: National Institutes of Health Clinical Center (CC)

Registration Number: NCT04674410

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy